 Home > Medical News > Latest Medical News > Anti-CD40L antibody submitted clinical application in China for the treatment of systemic lupus erythematosus

Anti-CD40L antibody submitted clinical application in China for the treatment of systemic lupus erythematosus

 Last Update: 2021-12-06
 Source: Internet
 Author: User

Tags

shelf life drug

dca drug

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

ArticleMedicine Guanlan

On November 18, the Center for Drug Evaluation (CDE) of the National Medical Products Administration of China announced that UCB has submitted a clinical trial application for dapirolizumab pegol monoclonal antibody for injection in China

Screenshot source: CDE official website

Systemic lupus erythematosus is a chronic systemic autoimmune disease that is clinically manifested as symptoms of multi-system damage.

Although SLE patients have a huge clinical need for innovative therapies, the development of new drugs in this field is particularly difficult

Dapirolizumab pegol is an anti-CD40L antibody jointly developed by U.

Public information shows that dapirolizumab pegol has previously obtained some clinical data in a phase 2b clinical trial for systemic lupus erythematosus

Although the primary clinical endpoint (24-week BICLA index) was not reached, the candidate drug also showed good tolerability and certain effectiveness in the study

Reference materials:

[1] Center for Drug Evaluation of China National Medical Products Administration.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

jobs united states(236)

united states jobs(223)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

ups united states(221)

announcements today(81)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.